Teva announces launch of new generic drug
The generic drug giant has 180 days of exclusivity for its generic version of Niaspan, a niacin-extended release tablet marketed by AbbVie.
Teva Pharmaceuticals is launching a generic version of a drug with $1.1 billion in sales in the U.S. market, the generic drug giant announced Friday.
register with haaretz
Like us on Facebook and get articles directly in your news feed